Mettler-Toledo Intl Analyst Ratings

Benzinga21minutes ago

Jefferies Assumes Mettler-Toledo Intl at Underperform, Raises Price Target to $1250

Benzinga5minutes ago

BioNTech Analyst Ratings

Benzinga05:29

Needham: Reiterates that Moderna (MRNA.US) holds the rating.

Zhitong Finance04:40

Moderna Analyst Ratings

Benzinga04:33

Moderna: Royal Bank of Canada raised the target price from $135 to $160

Zhitong Finance01:40

METTLER TOLEDO INTERNATIONAL CORPORATION: Jefferies assumes an underwriting rating of poor performance; targets a share price of $1,250 to $1,230

Zhitong Finance01:07

RBC Raises Moderna's Price Target to $160 From $135

MT NewswiresMay 31 13:46

BMO Capital Maintains Outperform on Vertex Pharmaceuticals, Raises Price Target to $500

BenzingaMay 31 08:42

Vertex Pharmaceuticals Analyst Ratings

BenzingaMay 31 08:41

Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Gilead Sciences (GILD) and Sanofi (OtherSNYNF)

TipRanksMay 31 04:50

Hold Rating on Gilead Sciences Amid Trodelvy Trial Setbacks and Future Uncertainties

TipRanksMay 31 04:46

Analysts' Opinions Are Mixed on These Healthcare Stocks: Gilead Sciences (GILD), Biogen (BIIB) and Argenx Se (ARGX)

TipRanksMay 30 22:00

BioNTech Analyst Ratings

BenzingaMay 30 06:01

Royal Bank of Canada: Biogen (BIIB.US) rating was reaffirmed and adjusted from superior to superior market rating, with a target price of $317.00.

Zhitong FinanceMay 29 09:02

Biogen Analyst Ratings

BenzingaMay 29 08:58

RBC Capital Reiterates Outperform on Biogen, Maintains $317 Price Target

BenzingaMay 29 08:59

RBC Capital Sticks to Its Buy Rating for Biogen (BIIB)

TipRanksMay 29 05:46

IQVIA Holdings (IQV) Gets a Buy From Jefferies

TipRanksMay 28 07:05

Analysts Offer Insights on Healthcare Companies: Inari Medical (NARI), Biogen (BIIB) and SOPHiA GENETICS (SOPH)

TipRanksMay 28 05:50